On October 14, the 10th lecture of the "Pilot" series of lectures by Beijing Medical Science and Technology Innovation Academicians and Scholars was held in Beijing. Two Beijing Scholars, Zhou Yujie, Executive Vice President of Beijing Anzhen Hospital Affiliated to Capital Medical University, and Shen Lin, Director of the Digestive Oncology Department, Peking University Cancer Hospital, gave wonderful lectures.
The lecture was hosted by Zhang Jian, Director of the Capital Institute of Pediatrics. Deng Pingji, Deputy Director of the Municipal Health Commission, and leaders, scientific research managers, and scientific researchers from 22 municipal hospitals and 18 municipal scientific research institutes attended the lecture.
Zhou Yujie gave a lecture on the "Challenges and Innovative Development in the Diagnosis and Treatment of Cardiovascular Diseases". Through a series of real and vivid cases, he analyzed the innovation and latest development trends in the field of cardiovascular interventional equipment from three dimensions, including coronary heart disease intervention, structural heart disease intervention, and other cardiac intervention. He reviewed the process of assisting the first domestic innovative product "Reserve Score Calculation Software for Coronary Blood Flow" to be approved for listing, and introduced the important progress made by the team in the targeted treatment of vulnerable plaques with nano-drug-loaded particles.
Shen Lin focused on "Translational Research to Promote New Drug Development and Discipline Development” and emphasized that clinicians should conduct research to solve clinical problems and meet patient need. It is necessary to promote the in-depth integration of clinical research, basic research, and translational research. She introduced the precise translational research support platform in detail established based on actual clinical problems, as well as the high-quality sample library, anthropomorphic model library and multi-dimensional detection platform. By introducing the team's research results, she explained that translational research reveals the molecular biological characteristics of gastrointestinal tumors, discovers potential markers for multi-dimensional immunotherapy, and promotes new drug development and discipline development.
In order to accelerate the improvement of the medical and technological innovation in the capital, promote the high-quality development of the health and biomedicine industry in Beijing, and accelerate the construction of an international science and technology innovation center, the Municipal Health Commission launched the Beijing Medical Science and Technology Innovation "Pilot" series of lectures in January this year, which provided a platform for the medical and technological workers in Beijing to communicate with outstanding scientists and created a good innovation atmosphere of respecting talents and open collaboration. So far, 10 series of lectures and 3 special lectures have been held. A total of 11 academicians and 12 Beijing scholars shared their research experiences and experiences with the medical and technological workers in Beijing and put forward expectations and suggestions for the growth of young medical and technological workers. The "Pilot" series of lectures has attracted much attention and has become a brand event for the capital's medical and technological innovation.